Urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive graves' ophthalmopathy;Ocena wydalania z moczem glikozaminoglikanów (GAG) w trakcie leczenia postȩpuja̧cej oftalmopatii obrzȩkowo-naciekowej w przebiegu choroby gravesa i basedowa

Polskie Archiwum Medycyny Wewnetrznej

Volumn 105, Issue 2, 2001, Pages 139-144

  Pilarska, Krystyna ^a   Kulig, Grzegorz ^a   Krzystolik, Zofia ^b  

^a Klinika Endokrynologii   (Poland)

^b Kat i Klinika Okulistyki PAM w S

Author keywords

Glycosaminoglycans; Graves' ophthalmopathy

Indexed keywords

GLYCOSAMINOGLYCAN; METHYLPREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; HYDROPHILICITY; IMMUNOSUPPRESSIVE TREATMENT; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 14344281423     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kiljanski J.I., Nebes V., Wall J.R.: The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy. Int. Arch. Immunol., 1995, 106, 204.
2. + and specifically recognize autologous fibroblasts. J. Clin. Invest., 1994, 93, 2738.
3. De Carli M., D'Elios M.M., Mariotti S. i wsp. Cytolytic T cells with Th1 - like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab., 1993, 77, 1120.
4. Korducki J.M., Lofyus S.J., Bahn R.S.: Stimulation of glycosaminoglycan production in cultured retroocular fibroblasts. Invest. Ophthalmol. Vis. Sci., 1992, 33, 2037.
5. Smith T.J, Bahn R.S., Gorman C.A., Cheavens M.: Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J. Clin. Endocrinol. Metab., 1991, 72, 1169.
6. Imai Y., Odajima R., Inoue Y., Shishiba Y.: Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopahty in culture. Acta. Endocrinol., 1992, 126, 541.
7. Poulsen J.H.: Urine and tissue glycosaminoglycans and their interrelations. Dan. Med. Buli., 1986, 33, 33.
8. Hansen Ch., Otto E., Kuhlemann K., Forster G., Kahaly G.J.: Glycosaminoglycans in autoimmunity. Clin Exp Rheumatology., 1996, 14 (suppl. 15), S59.
9. Bitter T., Muir H.M.: A modified uronic acid carbazole reaction. Analytical Biochemistry, 1962, 4, 330.
10. Weetman A.P.: Thyroid associated eye disease: Pathophysiology. Lancet, 1991, 388, 25.
11. Heufelder A.E., Bahn R.S.: Detection and localization of cytokine immunoreactivity in retro-ocularconnective tissue in Graves ophthalmopathy. Eur. J. Clin. Invest., 1993, 23, 10.
12. De Groot L.J., Gorman C.A., Pinchera A. Bartalena L: Therapeutic controversies. Radiation and Graves' ophthalmopathy. J. Clin. Metabol 1995; 80, 339-344.
13. Orcutt J.C., Kinypun J.L.: Radiation and Graves' ophthalmopathy. J. Glin. Endocrinol. Metabol., 1995, 80, 254.
14. Kahaly G., Stover C., Beyer J., Schuler M.: Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity, 1992, 13, 81.
15. Kahaly G., Hansen C., Beyer J., Winand R.: Plasma glycosaminoglycans in endocrine ophthalmopathy. J. Endocrinol. Invest., 1994, 17, 45.
16. Bahn R. A., Heufelder A. E.: Pathogenesis of Graves' ophthalmopathy. N. Engl. J. Med., 1993, 329, 1468.